An earlier version of this report had the wrong consensus and revenue numbers. It has been corrected. Shares of Biogen Inc. BIIB, -1.92% were down 3.7% in premarket trading on Thursday after the compa...
Tag: Biogens
Biogen’s Alzheimer’s Drug Aduhelm Has Another Shot at Success
Illustration by Elias Stein Text size Biogen ’s Alzheimer’s disease therapy, Aduhelm, has been a disappointment for the company since its Food and Drug Administration approval last spring, with early ...
Why Biogen’s Alzheimer’s drug Aduhelm is so controversial
The U.S. Food and Drug Administration’s approval of Biogen’s Alzheimer’s drug Aduhelm in June was heralded as a historic triumph in the fight against a disease that kills thousands o...